After-Hours Movers: Bed Bath & Beyond Gains on Insider Buys; USANA Down on Warning
Investing.com
Published Jul 06, 2022 01:51PM ET
Updated Jul 06, 2022 05:53PM ET
After-Hours Stock Movers:
CytomX Therapeutics, Inc. (Nasdaq: NASDAQ:CTMX) 28% LOWER; announced that the Phase 2 study of praluzatamab ravtansine in patients with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2 (HER2)-non-amplified breast cancer (Arm A) met its primary efficacy endpoint of confirmed objective response rate (ORR) of greater than 10 percent by central radiology review. Praluzatamab ravtansine is a DM4-conjugated, conditionally activated antibody-drug conjugate (ADC) targeting CD166 and is wholly owned by CytomX.
Veru, Inc. (NASDAQ:VERU) 19% HIGHER; Adds to 13% intra-day gains after the publication of Phase 3 data demonstrating that Sabizabulin treatment significantly reduced deaths in high-risk hospitalized COVID-19 patients.
USANA Health Sciences, Inc. (NYSE:USNA) 10% LOWER; announced preliminary results for the second quarter ended July 2, 2022, and provided an updated outlook for fiscal year 2022. The Company anticipates that second quarter 2022 net sales will be approximately $265 million, which compares with $337 million in the prior-year period. Earnings per share for the quarter are expected to be approximately $1.05, which compares with $1.87 during the second quarter of 2021. (Consensus sees Q2 EPS of $1.26 on revenue of $272.8 million)
Avalo Therapeutics Inc (NASDAQ:AVTX) 8% LOWER; announced a one-for-twelve reverse stock split of the Company's common stock, par value $0.001, which will be effective at 5:00 pm Eastern Time tomorrow, July 7, 2022.
Bed Bath & Beyond (NASDAQ:BBBY) 7% HIGHER; Interim CEO Sue Gove and two directors buy stock.
GameStop Corp. (NYSE:GME) 7% HIGHER; announced that its Board of Directors has approved and declared a four-for-one split of the Company’s Class A common stock in the form of a stock dividend.
Get The News You Want
Written By: Investing.com
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.